The potent anti-HIV activity of CXCL12γ correlates with efficient CXCR4 binding and internalization

Journal of Virology

Volumn 84, Issue 5, 2010, Pages 2563-2572

  Altenburg, Jeffrey D ^a   Jin, Qingwen ^a   Alkhatib, Bashar ^b   Alkhatib, Ghalib ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Biology SL332   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; PROTEOHEPARAN SULFATE; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1GAMMA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CHEMOTAXIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN VARIANT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; VIRUS MUTANT;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CHEMOKINE CXCL12; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CXCR4; SEQUENCE ALIGNMENT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77649209816     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00342-09     Document Type: Article

References (33)

1. + cells. J. Virol. 78:2277-2287.
2. Altenburg, J. D., H. E. Broxmeyer, Q. Jin, S. Cooper, S. Basu, and G. Alkhatib. 2007. A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent HIV-1 inhibitor with weak chemotaxis and cell survival activities. J. Virol. 81:8140-8148.
3. Amara, A., S. L. Gall, O. Schwartz, J. Salamero, M. Montes, P. Loetscher, M. Baggiolini, J. L. Virelizier, and F. Arenzana-Seisdedos. 1997. HIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med. 186:139-146.
4. Amara, A., O. Lorthioir, A. Valenzuela, A. Magerus, M. Thelen, M. Montes, J. L. Virelizier, M. Delepierre, F. Baleux, H. Lortat-Jacob, and F. Arenzana-Seisdedos. 1999. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J. Biol. Chem. 274: 23916-23925.
5. Arenzana-Seisdedos, F., J. L. Virelizier, D. Rousset, I. Clark-Lewis, P. Loetscher, B. Moser, and M. Baggiolini. 1996. HIV blocked by chemokine antagonist. Nature 383:400.
6. Balabanian, K., B. Lagane, S. Infantino, K. Y. Chow, J. Harriague, B. Moepps, F. Arenzana-Seisdedos, M. Thelen, and F. Bachelerie. 2005. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 280:35760-35766.
7. Banfield, B. W., Y. Leduc, L. Esford, K. Schubert, and F. Tufaro. 1995. Sequential isolation of proteoglycan synthesis mutants by using herpes simplex virus as a selective agent: evidence for a proteoglycan-independent virus entry pathway. J. Virol. 69:3290-3298.
8. Blanpain, C., I. Migeotte, B. Lee, J. Vakili, B. J. Doranz, C. Govaerts, G. Vassart, R. W. Doms, and M. Parmentier. 1999. CCR5 binds multiple CCchemokines: MCP-3 acts as a natural antagonist. Blood 94:1899-1905.
9. Bleul, C. C., M. Farzan, H. Choe, C. Parolin, I. Clark-Lewis, J. Sodroski, and T. A. Springer. 1996. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382:829-833.
10. Burger, J. A., and T. J. Kipps. 2006. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 107:1761-1767.
11. Burns, J. M., B. C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z. Miao, M. E. Penfold, M. J. Sunshine, D. R. Littman, C. J. Kuo, K. Wei, B. E. McMaster, K. Wright, M. C. Howard, and T. J. Schall. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203:2201-2213.
12. Chackerian, B., E. M. Long, P. A. Luciw, and J. Overbaugh. 1997. Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J. Virol. 71:3932-3939.
13. Donzella, G. A., D. Schols, S. W. Lin, J. A. Este, K. A. Nagashima, P. J. Maddon, G. P. Allaway, T. P. Sakmar, G. Henson, E. De Clercq, and J. P. Moore. 1998. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co receptor. Nat. Med. 4:72-77.
14. Gleichmann, M., C. Gillen, M. Czardybon, F. Bosse, R. Greiner-Petter, J. Auer, and H. W. Muller. 2000. Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur. J. Neurosci. 12:1857-1866.
15. Hatse, S., K. Princen, G. Bridger, E. De Clercq, and D. Schols. 2002. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527:255-262.
16. Lagane, B., K. Y. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie. 2008. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. Blood 112:34-44.
17. Laguri, C., R. Sadir, P. Rueda, F. Baleux, P. Gans, F. Arenzana-Seisdedos, and H. Lortat-Jacob. 2007. The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS One 2:e1110.
18. Marchese, A., M. M. Paing, B. R. Temple, and J. Trejo. 2008. G proteincoupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 48:601-629.
19. Matsumoto, M., S. Misawa, K. Tsumoto, I. Kumagai, H. Hayashi, and Y. Kobayashi. 2003. On-column refolding and characterization of soluble human interleukin-15 receptor alpha-chain produced in Escherichia coli. Protein Expr. Purif. 31:64-71.
20. Pastori, C., B. Weiser, C. Barassi, C. Uberti-Foppa, S. Ghezzi, R. Longhi, G. Calori, H. Burger, K. Kemal, G. Poli, A. Lazzarin, and L. Lopalco. 2006. Long-lasting CCR5 internalization by antibodies in a subset of long-term nonprogressors: a possible protective effect against disease progression. Blood 107:4825-4833.
21. Platt, E. J., K. Wehrly, S. E. Kuhmann, B. Chesebro, and D. Kabat. 1998. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72:2855-2864.
22. Proudfoot, A. E., S. Fritchley, F. Borlat, J. P. Shaw, F. Vilbois, C. Zwahlen, A. Trkola, D. Marchant, P. R. Clapham, and T. N. Wells. 2001. The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem. 276:10620-10626.
23. Rajarathnam, K., B. D. Sykes, B. Dewald, M. Baggiolini, and I. Clark-Lewis. 1999. Disulfide bridges in interleukin-8 probed using non-natural disulfide analogues: dissociation of roles in structure from function. Biochemistry 38:7653-7658.
24. Rueda, P., K. Balabanian, B. Lagane, I. Staropoli, K. Chow, A. Levoye, C. Laguri, R. Sadir, T. Delaunay, E. Izquierdo, J. L. Pablos, E. Lendinez, A. Caruz, D. Franco, F. Baleux, H. Lortat-Jacob, and F. Arenzana-Seisdedos. 2008. The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS One 3:e2543.
25. Sadir, R., F. Baleux, A. Grosdidier, A. Imberty, and H. Lortat-Jacob. 2001. Characterization of the stromal cell-derived factor-1alpha-heparin complex. J. Biol. Chem. 276:8288-8296.
26. Schols, D., J. A. Este, G. Henson, and E. De Clercq. 1997. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor fusin/ CXCR-4. Antiviral Res. 35:147-156.
27. Shirozu, M., T. Nakano, J. Inazawa, K. Tashiro, H. Tada, T. Shinohara, and T. Honjo. 1995. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 28:495-500.
28. Tan, Y., J. Du, S. Cai, X. Li, W. Ma, Z. Guo, H. Chen, Z. Huang, J. Xiao, L. Cai, and S. Cai. 2006. Cloning and characterizing mutated human stromal cell-derived factor-1 (SDF-1): C-terminal alpha-helix of SDF-1alpha plays a critical role in CXCR4 activation and signaling, but not in CXCR4 binding affinity. Exp. Hematol. 34:1553-1562.
29. Valenzuela-Fernandez, A., T. Palanche, A. Amara, A. Magerus, R. Altmeyer, T. Delaunay, J. L. Virelizier, F. Baleux, J. L. Galzi, and F. Arenzana-Seisdedos. 2001. Optimal inhibition of X4 HIV isolates by the CXC chemokine stromal cell-derived factor 1 alpha requires interaction with cell surface heparan sulfate proteoglycans. J. Biol. Chem. 276:26550-26558.
30. Viola, A., and A. D. Luster. 2008. Chemokines and their receptors: drug targets in immunity and inflammation. Annu. Rev. Pharmacol. Toxicol. 48: 171-197.
31. Wei, X., J. M. Decker, H. Liu, Z. Zhang, R. B. Arani, J. M. Kilby, M. S. Saag, X. Wu, G. M. Shaw, and J. C. Kappes. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
32. Williams, M. A., C. M. Cave, G. Quaid, C. Robinson, T. J. Daly, D. Witt, A. B. Lentsch, and J. S. Solomkin. 2005. Interleukin 8 dimerization as a mechanism for regulation of neutrophil adherence-dependent oxidant production. Shock 23:371-376.
33. Yu, L., J. Cecil, S. B. Peng, J. Schrementi, S. Kovacevic, D. Paul, E. W. Su, and J. Wang. 2006. Identification and expression of novel isoforms of human stromal cell-derived factor 1. Gene 374:174-179.